RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $980K of Relay Therapeutics, Inc.
Sold$979,886
$20.33Price
48,199Shares
−8%Stake
What RLAY did after the filing
- The stock from Wed, Aug 19 open, $21.05
- −12.2%
- S&P 500, same days
- −0.8%
Measured over 30 trading days, to the Oct 1 close.
Traded Mon, Aug 17. Filed Tue, Aug 18, 4:17 PM ET, after the close. Returns use the Aug 19 open and the Oct 1 close. Not investment advice.